NZSA asked for more information on succession plans for Justine Smyth after last year’s AGM, but it has not yet been forthcoming.
CEO Simon Mander says Covid is muddying company's prospects at present.
The NZX-listed honey, skincare, and supplements company has written down its newly-acquired honey business.
Company’s 12 dealerships restricted from fully operating for 108 days.
Underlying profit up 42% at the listed aged care business.
Building consents skyrocket - but do supply costs for glass maker.
The retirement operator recorded a full-year profit of $2.7m.
Newly-listed tech company reports higher revenue but wider loss for FY22.
Potential buyers are believed to have made indicative bids and are now going though due diligence.
Pharmacy operating profit up 49% in 2022.